Accelerated TMS for Freezing of Gait in Parkinson's Disease
Trial
N/A
Recruiting
Jan. 6, 2026
Network-based biOmarker Discovery of Neurodegenerative Diseases Using Multimodal Connectivity
Trial
N/A
Recruiting
Jan. 4, 2026
Bilateral Subthalamic Stimulation in PD Patients With Impulse Control Disorders - STIMPulseControl
Trial
N/A
Recruiting
Jan. 4, 2026
Study on the Efficacy of Temporal Interference Stimulation (TIS) for Parkinson's Disease
Trial
N/A
Not yet recruiting
Dec. 30, 2025
Clinical Study to Evaluate XS411 in Treatment of Early-onset Parkinson's Disease
Trial
Phase 1
Recruiting
Dec. 28, 2025
PET Imaging Evaluation of [11C]SY08
Trial
Early Phase 1
Recruiting
Dec. 23, 2025
Movement Improves Brain Health and Cognition in Parkinson's Disease
Trial
N/A
Recruiting
Dec. 22, 2025
Relationship Between Immunosuppressive Treatment Status and Clinical Course of Parkinson's Disease
Trial
N/A
Recruiting
Dec. 22, 2025
Biological Determinants and Neural Compensation of Dysphagia in Parkinson's Disease
Trial
N/A
Recruiting
Dec. 22, 2025
Evaluation of a New Communication Aid Tool to Favor Global Patient Centered Care
Trial
N/A
Recruiting
Dec. 22, 2025
Prevention-in-PD-Study
Trial
N/A
Not yet recruiting
Dec. 21, 2025
TMS-related Measures as Biomarker of Cognitive Impairment in PD
Trial
N/A
Recruiting
Dec. 21, 2025
Safety and Usability of the Cionic Neural Sleeve for Parkinson's Disease
Trial
N/A
Recruiting
Dec. 17, 2025
Terazosin And Metabolic Engagement in Parkinson's Disease
Trial
Phase 1
Not yet recruiting
Dec. 17, 2025
tDCS as Treatment for Motor Function
Trial
N/A
Recruiting
Dec. 17, 2025
Study on Preliminary Safety and Efficacy of Adaptive DBS Aligned to Locomotor States to Improve Locomotor Functions in Parkinson's Patients
Trial
N/A
Recruiting
Dec. 16, 2025
Cortical Correlates of Gait in Parkinson's Disease: Impact of Medication and Cueing
Trial
N/A
Recruiting
Dec. 16, 2025
Efficacy, Safety, Tolerability, and Biomarker Effects of GT-02287 in Early Parkinson's Disease
Trial
Phase 2
Not yet recruiting
Dec. 11, 2025
An Open-label, Observational, Long-term Follow-up Study Evaluating the Safety and Efficacy of RGL-193 Putamen Injection in Patients With Primary Parkinson's Disease
Trial
N/A
Not yet recruiting
Dec. 11, 2025